Following the expiry of Merial's UK patent on the fipronil/S-methoprene combination used in Frontline Combo comes the launch of Amflee Combo, the first generic alternative.

Amflee Combo, a POM, is being launched by a newcomer to the UK market, a Slovenian company called Krka (pronounced kirka). The company says it plans to introduce a vast range of small and production animal products onto the UK market in the next few years. 

Killian Gaffney, Head of sales and marketing at Krka, says the company intends to support UK veterinary surgeons by offering high quality products and by building business relationships that will help protect veterinary incomes, at the same time as offering good value to their customers.

Killian said: "Amflee Combo has some unique features that we believe will set it apart from the competition. We know the combination of the two active ingredients in Amflee Combo is very effective for the treatment of fleas, ticks and biting lice and as part of a treatment strategy for flea allergy dermatitis in dogs and cats. S-methoprene is also effective against flea eggs and larvae in the environment.

"However, these ingredients can be susceptible to degradation when subjected to light and moisture, which is why each Amflee Combo pipette comes in its own special foil wrapper. The pipettes have also been designed for convenience of use, since we know that only 22% of owners apply spot-ons correctly¹."

A range of product and client literature to support the use of Amflee Combo is available by calling 01753 722 150.

Amflee Combo is available in a variety of packs for cats and different sized dogs, containing either three or six pipettes. The recommended treatment is one pipette every four weeks.

Further information about Amflee Combo or Krka is available at www.krka.co.uk

Reference

1. 1 El veterinario ante el cambio climatico Argos 107, 2010.

PS: Whilst you're here, take a moment to see our latest job opportunities for vet nurses.